U.S. Food Stock News

In recent commentary, Griffon (NYSE:GFF) was reported to be facing ongoing end-market challenges, with sales declining by 2.7% annually over the past two years and analysts forecasting a further 28.7% revenue decline over the next 12 months, signalling weaker demand across its home improvement and building products portfolio. This sharp expected revenue drop, coming on top of a multi-year sales decline, raises questions about how much internal efficiency gains and product innovation can...

V2X (VVX) shares are in focus after the company announced a new collaboration with Elastic, aimed at strengthening search, analytics, and data-driven mission support for government, defense, and intelligence clients. See our latest analysis for V2X. The collaboration with Elastic lands at a time when momentum in V2X shares has been building. The 90 day share price return of 24.67% sits alongside a 1 year total shareholder return of 35.89% and 3 year total shareholder return of 76.26%. This...

In March 2026, IonQ announced a series of partnerships, including a Quantum Innovation Centre with the University of Cambridge and an MOU with Korea Institute of Science and Technology Information to integrate its quantum hardware with NVIDIA-enabled high-performance computing infrastructure. These collaborations, alongside IonQ’s work with US federal agencies on secure quantum architectures, highlight how the company is positioning its platform at the intersection of quantum computing, AI,...

Gilead Sciences (NasdaqGS:GILD) has agreed to acquire Ouro Medicines, adding an FDA fast-tracked, orphan-designated T cell engager for autoimmune diseases to its pipeline. The company is also entering a major research partnership with Galapagos to co-develop and commercialize this first-in-class clinical asset for severe autoimmune conditions. These moves extend Gilead’s recent deal activity beyond oncology and broaden its inflammation and immunology portfolio. For you as an investor, this...

If you are wondering whether BeOne Medicines at US$274.73 is still a fair deal or already pricing in a lot of optimism, the valuation picture is the place to start. The stock has been volatile recently, with a 5.2% decline over the last week and a 24.1% decline over the last 30 days. Over longer periods, the 1 year return sits at 8.5% and the 3 year return at 22.2%, while the 5 year return is a 15.1% decline. Recent news coverage has focused on BeOne Medicines as part of the broader...

Recent commentary in March 2026 highlighted Boot Barn Holdings’ rapid store expansion across Texas, California, Florida, and Oklahoma, where new locations in underpenetrated markets have been generating stronger-than-expected performance and supporting expectations for higher demand and revenue over the coming year. An interesting angle is how this expansion into growth markets appears to be boosting customer acquisition and sales productivity, suggesting store rollout quality and market...

Lennar (LEN) shares are in focus after the homebuilder reported first quarter results showing lower revenue and net income year over year, issued new second quarter home delivery guidance, and updated investors on its multi year share repurchase program. See our latest analysis for Lennar. The earnings report and guidance update came against a backdrop of weaker momentum, with a 30 day share price return of 19.75% and a 1 year total shareholder return of 19.08%. The 3 year and 5 year total...

Rezolve AI (RZLV) heads into a busy week for investors, with its 2025 financial results due on March 30, 2026, and a high profile showcase of its agentic commerce platform at Shoptalk 2026. See our latest analysis for Rezolve AI. Rezolve AI's share price has climbed 26.5% over the past month but is still showing a 5.2% year to date share price decline, while the 1 year total shareholder return of 65.9% contrasts with a 3 year total shareholder loss of roughly 73.0%. This hints that recent...

LiveRamp Holdings director Brian O'Kelley has resigned from the Board. His departure removes a board member with industry experience in ad tech and data. The change adds a new governance factor for investors tracking NYSE:RAMP. LiveRamp Holdings (NYSE:RAMP) is drawing fresh attention after this boardroom change, with the share price recently at $27.41. Over the past 3 years the stock has returned 28.8%, while the 5-year return stands at a 45.9% decline, a mixed backdrop that can shape how...

Delta Air Lines stock moves after mixed recent returns Delta Air Lines (DAL) has seen a 2.7% move over the past day and a 7.1% gain over the past week, while the share price shows declines over the month and the past 3 months. See our latest analysis for Delta Air Lines. Set against a share price of US$65.13, Delta's recent 1-day and 7-day share price returns contrast with weaker 1-month, 3-month and year to date figures, while its 1-year and multi year total shareholder returns remain...

Science Applications International (SAIC) stock is in focus after the company reported a year over year revenue decline and missed Wall Street expectations, while management outlined a shift toward higher value contracts and cost efficiencies. See our latest analysis for Science Applications International. The recent earnings miss, revenue decline and fresh guidance for fiscal 2027 have come alongside active capital actions such as share repurchases and a continued dividend. The share price...

The Chemours Company recently completed a private offering of US$700,000,000 in 7.875% senior unsecured notes due 2034 and used the proceeds, alongside cash on hand, to redeem portions of its 5.750% senior notes due 2028 and plans to redeem its 5.375% senior notes due 2027. This refinancing reshapes Chemours' debt profile by extending maturities and altering interest costs, which can influence perceptions of its financial flexibility and risk. Next, we will examine how Chemours’ use of new...

Class action lawsuit puts Hercules Capital’s processes under scrutiny Hercules Capital (HTGC) is under fresh legal scrutiny after a new class action lawsuit tied to allegations about its deal sourcing, portfolio valuation practices, and classification of software related debt exposure. The complaint, filed following a Hunterbrook Media report and a sharp single day share price drop in February 2026, raises questions around the company’s internal controls and past disclosures to investors. See...

Insight Enterprises (NSIT) shares are in focus after the company announced a broad leadership transition, with Jack Azagury set to become President, CEO and board member on April 13, 2026. See our latest analysis for Insight Enterprises. The leadership reshuffle comes at a time when Insight Enterprises' share price has eased back, with a 7 day share price return of 12.63% and a 30 day share price return of 16.82% decline, while the 1 year total shareholder return of 55.67% decline points to...

Baker Hughes announced a major collaboration with Google Cloud to build AI enabled power optimization tools for global data centers. The company also reported large new equipment contracts tied to both hyperscale data center power needs and LNG export projects. These moves extend Baker Hughes' reach further into digital infrastructure energy and add to its LNG equipment backlog. Baker Hughes, listed as NasdaqGS:BKR, is leaning into data center power infrastructure at a time when digital...

Viking Holdings (NYSE:VIK) has floated out the Viking Libra, the world’s first hydrogen powered cruise ship. The vessel marks a key step toward zero emission cruising and is intended to address demand for lower impact travel options. This event has not been covered in recent updates and adds a new angle to the Viking Holdings story for investors. Viking Holdings, trading at $71.87, is coming off a 73.5% return over the past year, with shorter term moves including a 0.9% gain over the past...

Lockheed Martin (NYSE:LMT) is accelerating rare earth procurement and dual-sourcing after new Pentagon rules and active military operations began drawing down existing US stockpiles. The company sits at the center of an emerging rare earths supply crunch that touches core programs, including advanced platforms such as the F-35. Fresh regulatory deadlines and real-time combat demands are reshaping how LMT sources critical materials, with increased reliance on multiple suppliers and tighter...

In March 2026, SoundHound AI, Inc. announced multiple developments, including a major rollout of its Employee Assist “BaristAI” tool with Peet’s Coffee, a new Experis partnership for enterprise AI adoption, an edge-based agentic AI showcase at NVIDIA GTC 2026, and a planned CFO transition to co-founder James Hom as interim CFO. Together, these moves highlight SoundHound AI’s push to embed its conversational and agentic AI across retail, healthcare, and automotive use cases while reshaping...

Sigma Lithium recently resumed sales of high‑grade premium lithium oxide concentrate and completed its first fixed‑price sale of 400,000 tonnes of high‑purity lithium fines in 1Q26, targeting about US$20,000,000 in profit. An additional inventory of 300,000 tonnes of high‑purity fines, expected to generate at least US$15,000,000 in profit under current market conditions, highlights how commercializing stored product is becoming a central earnings lever for the business. We’ll now examine how...

If you are wondering whether EOG Resources at around US$139.68 is still offering value or starting to look fully priced, the key is to break its current share price down against what the business might be worth. The stock has recently shown strong momentum, with returns of 3.8% over 7 days, 13.5% over 30 days, 30.2% year to date, 12.9% over 1 year, 43.1% over 3 years, and 142.2% over 5 years, which naturally raises questions about what is already reflected in the price. Recent coverage has...

What recent performance says about Cytokinetics Cytokinetics (CYTK) has been on many watchlists after recent trading, with the stock showing a 1 day return of 1.22% and a modest 0.20% move over the past week. Over longer periods, the share price shows a 10.29% decline over the past month and a 3.70% decline over the past 3 months, while the 1 year total return stands at 30.88%. See our latest analysis for Cytokinetics. That recent share price pullback, including a 10.29% 1 month share price...

Crocs has already opened its first full-price store in the U.K. at Westfield Stratford City in East London, showcasing an expanded range of adult and kids footwear and accessories in a refreshed, high-visibility retail format. This move, alongside plans to open 200 to 250 stores globally in 2026, underscores Crocs’ push to deepen its direct-to-consumer and international footprint. We’ll now examine how Crocs’ first full-price U.K. store and broader international rollout could influence the...

Himax Technologies recently reported a strong Q4, with revenues modestly above analyst expectations and earnings per share matching estimates, while highlighting Q1 as the trough before anticipated sales improvement driven by new automotive projects and lean customer inventories. In parallel, the company is showcasing ultralow power AI endpoint solutions, advanced automotive display ICs, and AR microdisplays, signalling a broader push into AI-enabled edge devices and next-generation optical...

Colgate-Palmolive (NYSE:CL) has appointed Bristol Myers Squibb CEO Christopher S. Boerner to its Board of Directors. The company has also named Hardik Jhaveri as senior director of marketing for its South Asean hub. These board and leadership changes reflect a growing focus on healthcare expertise and regional execution in Southeast Asia. For a consumer products company like Colgate-Palmolive, which is deeply tied to oral care, personal care, and other everyday essentials, bringing in a...